Abstract: Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and, in some applications, a second active agent, to subjects in need thereof. The present technology relates to the treatment or prevention of atherosclerosis in mammals through the administration of a therapeutically effective amount of aromatic cationic peptides and, in some embodiments, a second active agent.

Abstract: Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and, in some applications, a second active agent, to subjects in need thereof. The present technology relates to the treatment or prevention of atherosclerosis in mammals through the administration of a therapeutically effective amount of aromatic cationic peptides and, in some embodiments, a second active agent.

Abstract: Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and in some applications, a second active agent chemically linked to the peptide, to subjects in need thereof.

Abstract: Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and, in some applications, a second active agent, to subjects in need thereof. The present technology relates to the treatment or prevention of atherosclerosis in mammals through the administration of a therapeutically effective amount of aromatic cationic peptides and, in some embodiments, a second active agent.

Abstract: Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and in some applications, a second active agent chemically linked to the peptide, to subjects in need thereof.

Abstract: Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and, in some applications, a second active agent, to subjects in need thereof. The present technology relates to the treatment or prevention of atherosclerosis in mammals through the administration of a therapeutically effective amount of aromatic cationic peptides and, in some embodiments, a second active agent.

Abstract: Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and in some applications, a second active agent chemically linked to the peptide, to subjects in need thereof.

Abstract: A method and system for decreasing the concentration of at least one metal in an aqueous solution. The metal may be molybdenum, tungsten, or both. An aqueous solution is introduced into at least one reaction zone, and at least one source of hydroxide ions is provided into the at least one reaction zone in an amount sufficient to precipitate at least some of the mass of the at least one metal. The aqueous solution includes a mass of the at least one metal and a mass of at least one reducing agent. The at least one reducing agent includes at least ferrous iron from at least one source of the at least one reducing agent. A composition of tungsten ferrite or molybdenum tungsten ferrite may be formed. The method may be used for purifying water, for the refining of metals, or to facilitate a chemical analytical determination.

Abstract: A method for removal of material from a workpiece is disclosed. The method comprises the steps of providing a workpiece; providing an electrolyte, the electrolyte comprising hydrogen peroxide, in an amount of at least about 6 weight percent, and a source of hydroxyl ions; and contacting the workpiece with the electrolyte. The method provides the key advantage of high quality surface finish of the workpiece.

Abstract: A method and system for decreasing the concentration of at least one metal in an aqueous solution. The metal may be molybdenum, tungsten, or both. An aqueous solution is introduced into at least one reaction zone, and at least one source of hydroxide ions is provided into the at least one reaction zone in an amount sufficient to precipitate at least some of the mass of the at least one metal. The aqueous solution includes a mass of the at least one metal and a mass of at least one reducing agent. The at least one reducing agent includes at least ferrous iron from at least one source of the at least one reducing agent. A composition of tungsten ferrite or molybdenum tungsten ferrite may be formed. The method may be used for purifying water, for the refining of metals, or to facilitate a chemical analytical determination.